Cell and gene therapies present some unique challenges for forecasting and pricing. In this recorded webinar from 13 February 2024, Gary Johnson shares his insights about the most important challenges and how they can be handled:
The key ways that cell and gene therapy do and do not differ from more “conventional” therapies.
The commercial significance of the fact that cell and gene therapies invariably enter the market with “one foot still in the lab” (i.e. with immature clinical data).
The vital importance of “hope-based therapy” (high levels of uncertainty) rather than “evidence-based therapy” and how customers (payers/prescribers) actually act when faced with these uncertainties.
... and more!
Submit your details to receive a link to the recorded webinar:
Please note that this webinar is only open to managers working in pharma/biotech/medtech companies. So, please enter your COMPANY EMAIL address.
Continue your learning
If you’d like to learn more from Gary, CELforPharma also offers two 2-day, hands-on courses that will get you up the learning curve quickly!
The Pharma Forecasting Course
With Gary Johnson & Sam Johnson
The Pharma Pricing Course
With Gary Johnson & Sam Johnson
Don’t miss future CELforPharma webinars
Subscribe to our newsletter to:
- Receive invitations to upcoming educational webinars
- Stay on top of the latest expert insights
- Get updates on our courses and training programmes